Understanding Stem Cell Classification and Applications

Stem cells are undifferentiated or poorly differentiated cells capable of self-renewal and, under specific conditions, differentiation into one or more functional cell types. With the development of regenerative medicine, induced pluripotent stem cells, organoids, and cell-engineering technologies, different types of stem cells have been widely used in studies of developmental mechanisms, disease modeling, drug screening, and tissue repair. Because different stem cells vary substantially in differentiation potential, origin, and tissue localization, accurately understanding their classification and application boundaries is an important foundation for stem cell research.

Keywords: stem cells; embryonic stem cells; induced pluripotent stem cells; iPSC; hematopoietic stem cells; mesenchymal stem cells; neural stem cells; cell differentiation

1 Basic Biological Characteristics of Stem Cells

1.1 Self-Renewal and Modes of Cell Division

Self-renewal enables stem cells to maintain their own cell pool while generating differentiated cells, and its outcome depends on different modes of cell division and microenvironmental regulation.

(1) Symmetric Self-Renewal

One stem cell produces two daughter cells that both retain stem-cell identity, thereby expanding the stem-cell pool. This mode is particularly important during embryonic development, tissue growth, or in vitro expansion.

(2) Asymmetric Division

One stem cell produces one daughter cell that retains stemness and another daughter cell that enters a differentiation program. This allows continuous replenishment of functional tissue cells while maintaining the stem-cell pool and is an important regulatory mechanism for tissue homeostasis.

(3) Symmetric Differentiation

Both daughter cells enter differentiation programs, allowing rapid expansion of a specific lineage while simultaneously reducing the stem-cell reserve. Tissue injury, developmental stage, and niche signals can all alter the balance among different division modes.

1.2 Differentiation Potential

Differentiation potential reflects the range of cell lineages that a stem cell can generate and is an important basis for stem cell classification. A broader differentiation range indicates greater developmental potential but does not necessarily imply greater research or clinical value. For studies focused on a specific tissue, tissue-specific stem cells often have more direct biological relevance.

1.3 Stem Cell Niche and Maintenance of Stemness

The stem cell niche consists of neighboring cells, extracellular matrix, cytokines, nutrient status, oxygen tension, mechanical signals, and other factors that collectively regulate stem-cell quiescence, self-renewal, proliferation, and differentiation. Transcription factors such as OCT4, SOX2, and NANOG participate in pluripotency networks, whereas signals including FGF, TGF-β/Activin, Wnt, BMP, LIF, and Notch regulate stemness and lineage commitment according to cell type and developmental stage. Stem-cell state is therefore determined by the combined effects of intrinsic regulatory networks and the external microenvironment.

2 Classification Systems of Stem Cells

Stem cells can be classified according to differentiation potential, origin, and tissue localization. Totipotency, pluripotency, and multipotency describe the range of differentiation that cells can achieve, whereas ESC, iPSC, HSC, MSC, and NSC represent different origins, acquisition methods, or tissue-functional identities. These classification dimensions should not be used interchangeably.

2.1 Classification by Differentiation Potential

(1) Totipotency

Totipotency represents the highest level of developmental potential and allows formation of both the embryo proper and extraembryonic tissues that support embryonic development. In mammals, the fertilized egg and very early blastomeres are totipotent, but these cells are not conventional stem-cell lines that can be stably maintained long term in vitro. Totipotency is therefore used mainly to describe the developmental state of early embryonic cells.

(2) Pluripotency

Pluripotent stem cells (PSCs) can generate most cell types derived from the ectoderm, mesoderm, and endoderm but generally cannot independently form a complete organism and all extraembryonic tissues. ESCs and iPSCs are the most representative pluripotent stem-cell systems.

(3) Multipotency

Multipotent stem cells can generate multiple related lineages within a particular tissue system. For example, HSCs can generate erythrocytes, granulocytes, monocytes, lymphocytes, and other blood-cell lineages, whereas NSCs mainly generate neurons, astrocytes, oligodendrocytes, and other neural cell types.

(4) Oligopotency and Unipotency

Oligopotent cells have a more restricted differentiation range and can generate only a small number of related lineages. Unipotent stem cells primarily generate a single cell lineage while retaining a certain degree of self-renewal capacity, allowing them to participate in long-term renewal and injury repair of specific tissues.

Table 1 Comparison of Cells with Different Differentiation Potentials

Type	Differentiation Range	Representative Cells/States	Major Research Positioning
Totipotency	Embryo proper and extraembryonic tissues	Fertilized egg, very early blastomeres	Early embryonic development
Pluripotency	Most cell types derived from the three germ layers	ESC, iPSC	Development, directed differentiation, disease models
Multipotency	Multiple lineages within a single tissue system	HSC, NSC, etc.	Tissue development and regeneration
Oligopotency	A small number of related lineages	Some hematopoietic progenitor cells	Lineage restriction and maturation
Unipotency	Primarily a single lineage	Some tissue stem cells	Tissue renewal and repair

2.2 Relationship Between the Three Germ Layers and Pluripotency

One of the core criteria defining ESCs and iPSCs as pluripotent stem cells is their ability to generate cells derived from all three germ layers. The ectoderm, mesoderm, and endoderm subsequently give rise to different tissues and organs. Directed differentiation of PSCs therefore usually requires first establishing a specific germ-layer fate and then progressively inducing progenitor cells and mature functional cells.

Table 2 Three Germ Layers and Representative Differentiation Directions

Germ Layer	Representative Tissues or Cells
Ectoderm	Neurons, glial cells, epidermis, and related tissues
Mesoderm	Blood cells, cardiomyocytes, skeletal muscle, bone, cartilage, connective tissues, etc.
Endoderm	Hepatocytes, pancreatic cells, and some epithelial cells of the gastrointestinal and respiratory tracts

2.3 Classification by Origin and Acquisition Method

According to origin and acquisition method, stem-cell systems can include embryo-derived ESCs, tissue-specific stem cells from bone marrow and other adult tissues, stem/progenitor cells derived from perinatal tissues such as umbilical cord, and iPSCs generated through somatic-cell reprogramming. Different origins affect developmental state, culture requirements, differentiation capacity, and research and translational boundaries. Therefore, the biological properties of a cell cannot be inferred solely from the term “stem cell.”

2.4 Hierarchical Relationship Among Stem Cells, Progenitor Cells, and Mature Cells

Most tissue differentiation can be summarized as “stem cell → lineage-restricted progenitor cell → precursor cell → mature functional cell.” Stem cells generally possess longer-term self-renewal capacity, whereas progenitor cells have entered a more clearly defined lineage-restricted stage. As progenitor cells further become precursor cells, their proliferative and differentiation ranges continue to narrow until they ultimately form mature cells with specific structures and functions. HSCs and hematopoietic progenitor cells, or NSCs and neural progenitor cells, should therefore not be treated as completely equivalent concepts.

3 Common Stem Cell Systems and Their Biological Positioning

3.1 Embryonic Stem Cells

Embryonic stem cells (ESCs) are derived from cell populations associated with early embryos and possess long-term self-renewal capacity and the potential to differentiate into all three germ layers. ESCs are suitable for studies of pluripotency maintenance, early development, germ-layer establishment, and directed differentiation. Long-term culture, however, requires attention to spontaneous differentiation, culture adaptation, and genomic stability, and downstream applications must also control residual undifferentiated cells.

3.2 Induced Pluripotent Stem Cells

Induced pluripotent stem cells (iPSCs) are generated when differentiated somatic cells are reprogrammed back into a pluripotent state. Classical reprogramming can use factors such as OCT4, SOX2, KLF4, and c-MYC to reconstruct the pluripotency transcriptional network, allowing fibroblasts, peripheral blood-derived cells, and other somatic cells to regain broad differentiation potential similar to ESCs. Because iPSCs combine pluripotency with the donor’s genetic background, they are particularly suitable for patient-derived disease models, gene editing, and personalized pharmacological research.

3.3 Hematopoietic Stem Cells

Hematopoietic stem cells (HSCs) can sustain long-term hematopoiesis and generate myeloid and lymphoid lineages and are representative multipotent tissue stem cells. HSCs are mainly used in studies of hematopoietic lineage commitment, the bone-marrow microenvironment, hematological diseases, and hematopoietic reconstruction. Hematopoietic stem-cell transplantation is also one of the more established clinical applications of stem cells.

3.4 Mesenchymal Stromal/Stem Cells

Mesenchymal stromal/stem cells (MSCs) can be obtained from bone marrow, adipose tissue, umbilical cord, and other sources and can exhibit osteogenic, chondrogenic, and adipogenic differentiation under specific conditions. Beyond differentiation potential, MSC research also involves paracrine signaling, immunoregulation, and regulation of tissue microenvironments. Their biological evaluation therefore should not rely solely on tri-lineage differentiation results.

3.5 Neural Stem Cells

Neural stem cells (NSCs) can maintain a certain degree of self-renewal and differentiate into neural-system lineages including neurons, astrocytes, and oligodendrocytes. NSCs and PSC-derived neural progenitor cells are mainly used in studies of neurogenesis, brain development, neural injury, and neurodegenerative diseases.

3.6 Other Tissue-Specific Stem Cells

Intestinal stem cells, muscle satellite cells, epidermal stem cells, hair-follicle stem cells, and related populations mainly maintain homeostatic renewal and injury repair in their corresponding tissues. These cells are highly dependent on specific niches, and in vitro culture generally requires reconstruction of growth-factor, extracellular-matrix, and spatial signaling environments. They are also important cellular sources for tissue-organoid research.

3.7 Cancer Stem Cells

Cancer stem cells (CSCs) represent a functional subpopulation within tumors with self-renewal, tumor-maintenance, and heterogeneity-reconstitution capacities. This concept does not belong to exactly the same classification framework as stem cells defined by developmental differentiation potential. CSC research mainly focuses on tumor initiation, recurrence, metastasis, and therapeutic resistance and should therefore be distinguished from normal stem-cell systems such as ESCs and HSCs.

Table 3 Common Stem Cell Systems and Their Core Positioning

Stem Cell System	Differentiation Potential/Positioning	Core Characteristics	Major Research Directions
ESC	Pluripotent	Stable pluripotent state, broad differentiation range	Development, lineage differentiation
iPSC	Pluripotent	Retains donor genetic background	Disease modeling, gene editing, drug screening
HSC	Multipotent	Establishes multiple blood-cell lineages	Hematopoiesis, transplantation, hematological diseases
MSC	Multipotent	Mesenchymal differentiation, paracrine signaling, and immunoregulation	Bone and cartilage, tissue repair, microenvironment
NSC	Multipotent	Differentiation into neuronal and glial lineages	Neurogenesis, neurological diseases
Tissue-specific stem cells	Tissue-restricted	Retain strong tissue-specific characteristics	Tissue homeostasis, organoids, injury repair
CSC	Functional tumor subpopulation	Self-renewal, tumor maintenance	Tumor heterogeneity, recurrence, drug resistance

Table 4 Common Human Cytokines Used for Culture and Directed Differentiation of Different Stem Cell Types

Protein/Cytokine	Hematopoietic Stem Cells (HSC)	Embryonic Stem Cells (ESC)	Neural Stem Cells (NSC)	Induced Pluripotent Stem Cells (iPSC)	Mesenchymal Stem Cells (MSC)
FGF-2	√	√	√	√	√
EGF	√	√	√	√	√
TGF-β1	√	√			√
TGF-β3					√
BMP-4		√		√	√
Activin A		√
IL-3	√	√
SCF	√
Flt3-ligand	√
GM-CSF	√
G-CSF	√
M-CSF	√
LIF		√		√
TPO	√
VEGF165	√
FGF-8b			√
IL-6	√
SHH			√
CNTF			√	√
Noggin				√
PDGF-BB					√
R-spondin 1				√
HGF				√
Vitronectin		√		√

4 Major Applications of Different Stem Cells

4.1 Development and Lineage-Commitment Research

ESCs and iPSCs possess broad differentiation potential and can be used to model germ-layer formation and lineage commitment. By regulating signaling pathways such as Wnt, BMP, TGF-β/Activin, FGF, and Notch, cells can be directed from the pluripotent state toward ectodermal, mesodermal, or endodermal fates and subsequently differentiated into neural, cardiac, hepatic, pancreatic, and other cell types.

4.2 Patient-Derived Disease Models

After patient somatic cells are reprogrammed into iPSCs, they can be further differentiated into disease-relevant neurons, cardiomyocytes, hepatocytes, and other cells, thereby generating in vitro disease models while preserving the donor genetic background. Combined with CRISPR/Cas and other gene-editing technologies, isogenic controls can be established to further analyze causal relationships between specific genetic variants and disease phenotypes.

4.3 Hematopoiesis and Hematological Disease Research

HSCs directly correspond to the hematopoietic system and can be used to study stem-cell self-renewal, myeloid and lymphoid differentiation, the bone-marrow niche, and abnormal hematopoiesis in diseases such as leukemia. HSC transplantation and genetically modified HSCs also represent important directions for clinical translation of stem-cell technologies.

4.4 Neurogenesis and Neurological Disease Research

NSCs or PSC-derived neural progenitor cells can further generate neurons and glial cells and can be used to study neurogenesis, neural-network establishment, neurodegenerative changes, and neural injury. Patient-derived iPSCs can further connect disease-associated genotypes with neural-cell phenotypes.

4.5 Organoids and Three-Dimensional Tissue Models

Both tissue stem cells and PSCs can be used to establish organoids. Intestinal organoids can be generated from tissue-derived intestinal stem cells, whereas brain, kidney, retinal, and other organoids are often obtained through directed differentiation of PSCs. Organoids can reproduce some tissue structures, cellular compositions, and intercellular interactions, although vascular, immune, neural-innervation, and mechanical environments usually remain different from those of intact organs.

4.6 Drug Screening and Toxicity Evaluation

iPSC-derived cardiomyocytes, neural cells, hepatocytes, and other cell types can be used for disease-related drug screening and tissue-toxicity evaluation. These models can provide cellular backgrounds more closely resembling specific human tissues, but experimental reliability depends strongly on differentiation purity, functional maturity, culture standardization, and batch-to-batch consistency.

4.7 Regenerative Medicine and Cell Therapy

Stem cells and their derivatives can be used in tissue replacement, hematopoietic reconstruction, and regenerative-therapy research, but the clinical maturity of different systems varies substantially. HSC transplantation has become an established clinical application, whereas PSC-derived cells, MSCs, and other tissue stem cells require application-specific evaluation of differentiation purity, genetic stability, immune compatibility, tumorigenic risk, and long-term function.

4.8 Gene Editing and Cell Engineering

Stem-cell systems such as iPSCs and HSCs can be combined with CRISPR/Cas and other gene-editing technologies for disease-mutation correction, gene-function studies, and construction of engineered cells. After gene editing, genotype, potential off-target effects, clonal variation, stemness, and differentiation capacity must be reevaluated rather than treating successful editing as equivalent to adequate model quality.

5 Selection and Evaluation in Stem Cell Experiments

5.1 Selection of Cell Systems According to the Scientific Question

Cell-system selection should be driven by the research question rather than by simply pursuing higher differentiation potential. ESCs may be prioritized for early developmental research, iPSCs are suitable for studies requiring patient genetic backgrounds, HSCs should be selected for hematopoietic reconstruction and hematological-disease studies, neural-lineage research can use NSCs or PSC-derived neural cells, and tissue-homeostasis or organoid research is generally better suited to the corresponding tissue-specific stem cells.

5.2 Stemness and Cell Identity

PSCs usually require confirmation using pluripotency-network markers such as OCT4, SOX2, and NANOG together with cell morphology and differentiation potential. HSCs, MSCs, NSCs, and other systems require corresponding surface markers, transcription factors, and functional indicators. Positivity for a single marker is generally insufficient to define complete stem-cell identity.

5.3 Differentiation Purity and Functional Maturity

After directed differentiation, stem cells should be evaluated for lineage identity, proportion of target cells, and degree of functional maturity. For example, neural cells can be evaluated using markers such as TUBB3 together with synapse formation and electrical activity, whereas iPSC-derived cardiomyocytes can be assessed using contractility, electrophysiology, and calcium signaling. Expression of terminal markers does not necessarily indicate formation of fully mature functional cells.

5.4 Genetic Stability and Batch-to-Batch Consistency

Long-term culture, somatic-cell reprogramming, gene editing, and clonal selection can all induce genetic or epigenetic changes. PSCs in particular require attention to karyotype, copy-number variation, and adaptive clones arising during long-term culture. Standardization of culture conditions, passaging methods, and differentiation procedures is also necessary to reduce batch-to-batch variability.

5.5 Boundaries of Clinical Translation

Possessing stem-cell properties does not mean that a cell can be directly used therapeutically. Research-grade cells, GMP-grade raw materials, and clinical cell products are subject to different quality systems. Clinical translation also requires evaluation of source traceability, sterility and safety, genetic stability, differentiation purity, tumorigenic risk, immune compatibility, and long-term efficacy.

6 Common Questions in Stem Cell Research

6.1 Does Higher Pluripotency Mean Greater Research Value?

Differentiation potential describes the range of lineages that a cell can generate and does not directly represent experimental value. When a specific tissue is being studied, tissue-specific stem cells often have more direct biological relevance. The main advantages of PSCs lie in cross-lineage differentiation and model plasticity.

6.2 What Is the Core Difference Between ESCs and iPSCs?

ESCs are derived from cells associated with early embryos, whereas iPSCs are obtained by reprogramming differentiated somatic cells. Both are pluripotent, but iPSCs retain the donor genetic background and therefore have particular advantages in patient-derived disease models and personalized research.

6.3 Do iPSCs Still Belong to the Original Somatic Cell Type After Reprogramming?

Reprogramming reconstructs pluripotency-associated transcriptional and epigenetic networks and removes cells from their original terminally differentiated state. Their primary genetic background still derives from the original donor, but their cell-fate state and differentiation potential have changed substantially.

6.4 Can Stem Cells and Progenitor Cells Be Used Interchangeably?

Generally not. Progenitor cells have entered a more clearly lineage-restricted stage and usually have lower self-renewal capacity and a narrower differentiation range than upstream stem cells. Experimental design should clearly distinguish whether the study object is a stem cell, progenitor cell, precursor cell, or mature cell.

6.5 Is Positive Tri-Lineage Differentiation Sufficient to Establish MSC Identity?

No. Osteogenic, adipogenic, and chondrogenic differentiation are important components of MSC characterization but should be combined with corresponding phenotypic markers and functional evaluation required by the research objective. When paracrine or immunoregulatory functions are involved, corresponding functional evidence is particularly important.

6.6 Is Detection of a Single Marker Sufficient After Stem Cell Differentiation?

Usually not. Multiple lineage markers, the proportion of target cells, non-target cells, and residual undifferentiated cells should be evaluated together with indicators related to mature function.

6.7 Are Organoids Equivalent to Real Organs?

No. Organoids can reproduce some aspects of tissue structure, cellular composition, and function, but vascular, immune, neural, and mechanical microenvironments are generally incomplete. They are therefore more appropriately regarded as tissue-level in vitro models.

7 Products Related to Stem Cell Culture, Differentiation, and Characterization

7.1 Products Related to Pluripotent Stem Cell Maintenance and Directed Differentiation

Catalog #	Product Name	Grade & Purity	Mechanism/Target	Research Application
rp168392-GMP	Recombinant Human/Mouse/Rat Activin A GMP Protein	Animal Free, Carrier Free, Bioactive, ActiBioPure™, High Performance, ≥97%(SDS-PAGE&SEC-HPLC)	Activin A participates in pluripotency maintenance through Activin receptor–SMAD2/3 signaling and regulates early lineage fates including endoderm	Pluripotency and endoderm differentiation
rp329653	Recombinant Human BMP4 Protein	≥95%(SDS-PAGE)	BMP4 regulates germ-layer formation and lineage commitment through BMP receptor–SMAD1/5/8 signaling, with effects depending on differentiation stage and combinations with other signals	Germ-layer and lineage differentiation
rp156341	Recombinant Human Noggin Protein	Animal Free, Carrier Free, His Tag, PBS Only, ≥90%(SDS-PAGE), See COA	Noggin binds BMP ligands such as BMP2 and BMP4, limiting their interaction with receptors and suppressing BMP signaling	BMP inhibition and neural induction
rp168381-GMP	Recombinant Human Wnt-3a GMP Protein	Animal Free, Carrier Free, Bioactive, ActiBioPure™, High Performance, Fc Tag, PBS Only, ≥75%(SDS-PAGE)	Wnt3a activates canonical Wnt/β-catenin signaling through the Frizzled/LRP receptor complex and participates in regulation of pluripotency and germ-layer fate	Wnt-mediated fate regulation
C125082	CHIR-99021	Moligand™, ≥98%	Highly selective GSK-3α/β inhibitor that promotes β-catenin stabilization and enhances Wnt-related signaling by inhibiting GSK-3	Stemness and directed differentiation
Y412681	Y-27632 2HCl	Moligand™, ≥99%	ROCK inhibitor that reduces cytoskeletal contraction and related apoptosis after cell dissociation, improving survival of human PSCs after single-cell dissociation	PSC passaging and survival support
rp148270	Recombinant Human LIF Protein	Animal Free, Carrier Free, Bioactive, ActiBioPure™, Azide Free, High Performance, His Tag, ≥95%(SDS-PAGE)	LIF binds LIFR/gp130 and activates JAK/STAT and related signaling and participates in maintenance of the undifferentiated state in mouse ESC systems	Mouse ESC maintenance
W650792	Wnt/β-catenin agonist 2	≥99%	Activates Wnt/β-catenin-related signaling, enhances β-catenin-dependent transcription, and regulates cell fate	Wnt signaling research
F1521100	Fetal Bovine Serum (Stem Cell & Primary Cell Qualified)	Sterile-filtered, BioReagent, for cell culture	Provides proteins, growth factors, lipids, and adhesion-related components that can support culture of multiple stem-cell and primary-cell types	Basic stem-cell culture
Ab128778	Recombinant SOX2 Antibody	Recombinant, ExactAb™, Validated, 1.0 mg/mL	Specifically recognizes SOX2; SOX2 participates in the PSC pluripotency transcriptional network and is also an important state marker for neural stem/progenitor cells	SOX2 expression detection to support evaluation of pluripotency and NSC status

7.2 Products Related to Hematopoietic Stem Cells and Mesenchymal Stem Cells

Catalog #	Product Name	Grade & Purity	Mechanism/Target	Research Application
H1511075	Human Hematopoietic Stem Cell Expansion Cytokine Package (IL-3)	Sterile-filtered, BioReagent	Composed of cytokines including FLT3L, SCF, TPO, and IL-3, which act through their corresponding receptors to jointly support survival, expansion, and differentiation of hematopoietic stem/progenitor cells	HSC expansion culture
rp156013	Recombinant Human FLT-3 Ligand Protein	Carrier Free, His Tag, ≥95%(SDS-PAGE)	FLT3L binds FLT3 receptor and can cooperate with SCF, TPO, and related factors to support expansion of early hematopoietic stem/progenitor cells	Early hematopoietic-cell expansion
rp151299	Recombinant Human SCF Protein	Animal Free, Carrier Free, Bioactive, ActiBioPure™, Azide Free, High Performance, His Tag, ≥95%(SDS-PAGE)	SCF binds KIT/c-Kit and activates PI3K, RAS–ERK, STAT, and related pathways and is an important survival and proliferation factor for early hematopoietic cells	HSC maintenance and expansion
rp167459-GMP	Recombinant Human Thrombopoietin GMP Protein	Animal Free, Carrier Free, Bioactive, ActiBioPure™, High Performance, ≥95%(SDS-PAGE&SEC-HPLC)	TPO binds the MPL receptor, participates in HSC maintenance, and regulates megakaryocyte-related differentiation programs	HSC expansion and megakaryocytic differentiation
rp156005	Recombinant Human IL-6 Protein	Carrier Free, Bioactive, ActiBioPure™, Azide Free, High Performance, His Tag, PBS Only, ≥95%(SDS-PAGE)	IL-6 participates in hematopoietic-cell proliferation and differentiation through IL-6R/gp130–JAK/STAT and related signaling	Hematopoietic proliferation and differentiation
rp168377-GMP	Recombinant Human GM-CSF GMP Protein	Animal Free, Carrier Free, Bioactive, ActiBioPure™, High Performance, PBS Only, ≥97%(SDS-PAGE&SEC-HPLC)	GM-CSF acts through its corresponding cytokine receptor to promote proliferation and differentiation of granulocytic, monocytic/macrophage, and other myeloid progenitor cells	Myeloid-directed differentiation
Ab181105	CD34 Mouse mAb (Biotin)	ExactAb™, Azide Free, Validated, 0.5 mg/mL	Specifically recognizes human CD34 and can be used to detect CD34-positive hematopoietic stem/progenitor populations	Detection and phenotypic analysis of CD34-positive hematopoietic stem/progenitor populations
rp152261	Recombinant Human TGF-beta 1 Protein	Animal Free, Carrier Free, Bioactive, ActiBioPure™, High Performance, His Tag, ≥95%(SDS-PAGE)	TGF-β1 regulates cell proliferation, differentiation, and extracellular-matrix-related processes through TGFBR–SMAD signaling	MSC lineage differentiation
rp156175	Recombinant Human PDGF-BB Protein	Carrier Free, Bioactive, ActiBioPure™, High Performance, His Tag, ≥95%(SDS-PAGE), See COA	PDGF-BB activates PDGFR-related proliferation, migration, and survival signaling and is an important mitogen for multiple mesenchymal-derived cell types	MSC proliferation and migration
rp166633	Recombinant Human VEGF 165 Protein	Animal Free, Carrier Free, Bioactive, ActiBioPure™, High Performance, Sterile, His Tag, PBS Only, ≥98%(SDS-PAGE)	VEGF165 activates VEGFR-related signaling and promotes endothelial-cell proliferation, survival, and angiogenesis	Vascularized regeneration models
Ab095500	Recombinant CD90/Thy1 Antibody	Recombinant, ExactAb™, Validated, See COA	Specifically recognizes THY1/CD90; CD90 is a commonly used positive phenotypic marker for MSCs and should be evaluated together with other positive and negative markers	MSC phenotypic characterization
rp169605	Recombinant Human Endoglin/CD105 Protein	Animal Free, Carrier Free, Bioactive, ActiBioPure™, His Tag, PBS Only, ≥95%(SDS-PAGE), See COA	CD105/Endoglin is an accessory molecule associated with the TGF-β receptor complex and participates in vascular- and mesenchymal-cell-related signaling regulation	CD105/TGF-β research

7.3 Products Related to Neural Stem Cells and Neural-Lineage Differentiation

Catalog #	Product Name	Grade & Purity	Mechanism/Target	Research Application
rp215069	Recombinant Human EGF Protein	Carrier Free, Bioactive, ActiBioPure™, High Performance, PBS Only, ≥95%(SDS-PAGE), See COA	EGF binds EGFR and activates RAS–ERK, PI3K–AKT, and related signaling, promoting neural stem/progenitor-cell proliferation and survival	NSC expansion culture
rp143209-GMP	Recombinant Human BDNF GMP Protein	Animal Free, Carrier Free, Bioactive, ActiBioPure™, High Performance, Sterile, ≥70%(SDS-PAGE)	BDNF acts mainly through TrkB/NTRK2 signaling to promote neuronal survival, differentiation, axonal growth, and synaptic plasticity	Neuronal differentiation and maturation
rp168357-GMP	Recombinant Human GDNF GMP Protein	Animal Free, Carrier Free, Bioactive, ActiBioPure™, High Performance, PBS Only, ≥97%(SDS-PAGE&SEC-HPLC)	GDNF binds GFRA1 and promotes activation of the RET receptor complex, participating in survival, axonal growth, and functional maintenance of specific neuronal populations	Neural differentiation and survival
rp225846	Recombinant Human Nestin Protein	Carrier Free, ≥95%(SDS-PAGE), See COA	Nestin is an intermediate-filament protein highly expressed in neural stem/progenitor cells and participates in cytoskeletal organization during proliferative states	Neural progenitor-cell research
Ab219221	beta III Tubulin Mouse mAb (Biotin)	ExactAb™, Validated, High Performance, 0.5 mg/mL	Specifically recognizes TUBB3/βIII-Tubulin; TUBB3 is an important component of the neuronal microtubule system	Neuronal differentiation characterization
rp181238	Recombinant Human DLL4 Protein	Animal Free, Carrier Free, Bioactive, ActiBioPure™, His Tag, ≥95%(SDS-PAGE)	DLL4 acts as a Notch receptor ligand to regulate Notch signaling and participates in progenitor maintenance and lineage-fate decisions	Notch-mediated lineage commitment
Ab117712	Neurogenin 1/NEUROG1 Mouse mAb	See COA	Specifically recognizes NEUROG1; NEUROG1 is a neurogenesis-related bHLH transcription factor involved in neuronal differentiation programs	Neural-lineage characterization

Different types of stem cells provide an important technical foundation extending from basic developmental research to disease modeling and regenerative medicine. With continued advances in directed differentiation, organoids, and cell-engineering technologies, standardization of stem-cell models, functional maturity, and translational safety will become increasingly important directions for future research.

References

[1] Di Buduo C A, Aguilar A, Soprano P M, et al. Latest culture techniques: cracking the secrets of bone marrow to mass-produce erythrocytes and platelets ex vivo[J]. Haematologica, 2021, 106(4): 947-957. doi:10.3324/haematol.2020.262485.

[2] Derynck R, Zhang Y E. Smad-dependent and Smad-independent pathways in TGF-β family signalling[J]. Nature, 2003, 425(6958): 577-584.

[3] Zhang J, Li L. BMP signaling and stem cell regulation[J]. Developmental Biology, 2005, 284(1): 1-11.

For more related articles, please see below:

[1] Experimental induction of human mesenchymal stem cell immortalization with telomerase

[2] Mesenchymal Stem Cells (MSCs) Identification

[3] Experiments on culturing human corneal mesenchymal stem cells

[4] Sampling and isolation experiments of adipose-derived stem cells

[5] Human embryonic stem cell passaging culture

[6] Induction of multipotent stem cells

[7] Isolation and culture of stem cells

[8] Culture scheme of neural stem cells

[9] Applications of BMP Signaling Pathway Regulators in Stem Cell Differentiation, Organoid Culture and Developmental Research